Medical research

Target two forms of iron to control cystic fibrosis lung infection

The bacterium Pseudomonas aeruginosa needs iron to establish and maintain a biofilm in the lungs of cystic fibrosis patients, and therapies have been proposed to deprive the bacteria of this necessary element. However, these ...

Medical research

New insights on polymicrobial infections in chronic lung diseases

Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis. They display ...

Other

FDA approves lung preservation machine (Update)

Federal health regulators have approved a novel device that can preserve donated lungs outside the body for possible transplantation into critically ill patients.

Diseases, Conditions, Syndromes

Hypertonic saline may help babies with cystic fibrosis breathe better

Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany and published in the American Thoracic Society's American Journal of Respiratory ...

Medical research

Lung diseases share molecular signature

The fibrotic lung diseases BPD (bronchopulmonary dysplasia) and IPF (idiopathic pulmonary fibrosis) affect preterm infants and older adults, respectively. Evidence suggests that these diseases involve dysregulation of lung ...

Medical research

Screening system for lung sound analysis

A multi-channel recording device developed at TU Graz for pathological lung sounds and associated automatic lung sound analysis could support existing screening methods for early detection of, for example, COVID-19 infections. ...

Health

Happy patients, healthy lungs

Diseases like chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are hard to treat. Lung transplant is important option for people who do not benefit from other treatments, and understanding the outcomes ...

Diseases, Conditions, Syndromes

Ataluren Phase 3 trial results in nonsense mutation cystic fibrosis

PTC Therapeutics, Inc. today announced that the results of a Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis (nmCF) were published in Lancet Respiratory Medicine. The results demonstrated positive ...

page 35 from 39